|
1
|
Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.
|
Int Immunopharmacol
|
2011
|
0.98
|
|
2
|
Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.
|
Int Immunopharmacol
|
2009
|
0.90
|
|
3
|
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
|
Int Immunopharmacol
|
2011
|
0.83
|
|
4
|
Emodin is identified as the active component of ether extracts from Rhizoma Polygoni Cuspidati, for anti-MRSA activity.
|
Can J Physiol Pharmacol
|
2015
|
0.80
|
|
5
|
Design, synthesis and evaluation of the antibacterial enhancement activities of amino dihydroartemisinin derivatives.
|
Molecules
|
2013
|
0.79
|
|
6
|
Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approach.
|
Theor Biol Med Model
|
2013
|
0.79
|
|
7
|
Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA).
|
J Antibiot (Tokyo)
|
2013
|
0.78
|
|
8
|
The direct anti-MRSA effect of emodin via damaging cell membrane.
|
Appl Microbiol Biotechnol
|
2015
|
0.75
|